CAPR Latest News, Press Relases and Analysis

All

Press Releases

18 hours ago - By: Chartmill - Mentions: MVO GCO CCRN RGC ...

Let's take a look at the stocks that are in motion in today's session.

2 days ago - By: Chartmill - Mentions: CEP ACHC CMCT AEMD ...

Get insights into the top gainers and losers of Wednesday's pre-market session.

26 minutes ago - By: Capricor Therapeutics

Capricor Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock

15 hours ago - By: Capricor Therapeutics

Capricor Therapeutics Announces Proposed Public Offering of Common Stock

a day ago - By: Stocktwits - Mentions: IWM SBIO

Capricor’s Red-Hot Rally Has Wall Street And Retail Hooked — And Fresh DMD Data Could Keep Fueling The Fire

2 days ago - By: Stocktwits

‘Pharma Bro’ Martin Shkreli Calls His Capricor Therapeutics Short A 'Bad Call' After DMD Trial Delivers Surprise Win

2 days ago - By: Bloomberg

Capricor Soars on Drug Results That Could Reverse FDA Rejection

2 days ago - By: Stocktwits

Why Did Capricor Therapeutics Stock Skyrocket Today?

2 days ago - By: Capricor Therapeutics

Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy

2 days ago - By: Stocktwits - Mentions: SPY QQQ DIA MRVL ...

Nasdaq, S&P 500 Futures Point To Steady Open: Why CAPR, MRVL, AEO, GTLB, CRWD Are On Traders' Radar

4 days ago - By: Stocktwits - Mentions: IWMW VTWG

Capricor Therapeutics Stock Sparks Retail Frenzy As Traders Hail ‘Best Data’ Ahead Of DMD Data Readout

11 days ago - By: Chartmill - Mentions: SUPX CMCT ENLV AEHL ...

Which stocks are experiencing notable movement on Monday?

11 days ago - By: Chartmill - Mentions: SUPX CMCT MBRX ENLV ...

Top movers in Monday's session

11 days ago - By: Stocktwits

‘Pharma Bro’ Martin Shkreli Goes Short On Capricor Therapeutics – Stock Tumbles 17%

24 days ago - By: Stocktwits

Capricor Therapeutics Stock Jumps After-Hours As Retail Cheers Fresh FDA Attempt After Duchenne Therapy Rejection

24 days ago - By: Stocktwits - Mentions: TSLA

Tesla Chair Declares Start Of 'Whole New Book' As Musk's 423 Million Share Award Is Locked In — All Hope Pinned On Robotaxi, Optimus

25 days ago - By: Benzinga - Mentions: TRNR OKLO LMFA ZBAO ...

Top Stocks With Earnings This Week: Plug, Oklo, Circle And More

a month ago - By: Benzinga

Preview: Capricor Therapeutics's Earnings

a month ago - By: Zacks Investment Research - Mentions: CBLL

CeriBell, Inc. (CBLL) Reports Q3 Loss, Beats Revenue Estimates

a month ago - By: Stocktwits

Capricor Therapeutics Stock Becomes Talk Of Retail Town On DMD Study; Retail Sees New Hope After Sarepta Setback

a month ago - By: Capricor Therapeutics

Capricor Therapeutics Publishes Peer-Reviewed Study in Biomedicines Describing the Mechanism of Action and Potency Assay for its Investigational Cell Therapy, Deramiocel

a month ago - By: Capricor Therapeutics

Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10

a month ago - By: Kuehn Law, PLLC

Kuehn Law Encourages Investors of Capricor Therapeutics, Inc. to Contact Law Firm

2 months ago - By: Bragar Eagel & Squire

CAPRICOR INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Capricor Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

2 months ago - By: Stocktwits - Mentions: VTWG ISCB

Capricor Stock Rises Pre-Market Over Fresh Hopes of Deramiocel Approval In Treating Genetic Disorder

2 months ago - By: Capricor Therapeutics

Capricor Therapeutics Provides Regulatory Update on Deramiocel Program for Duchenne Muscular Dystrophy Following Type A Meeting

3 months ago - By: Bragar Eagel & Squire

CAPRICOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Capricor Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

3 months ago - By: THE ROSEN LAW FIRM, P. A.

CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit

3 months ago - By: Faruqi & Faruqi, LLP

FINAL DEADLINE ALERT: Faruqi & Faruqi Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 - CAPR

CAPRICOR THERAPEUTICS INC (CAPR) Stock News

CAPR Latest News, Press Relases and Analysis